Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Paulli M"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-4 z 4
    Tytuł:
    Systemic mastocytosis and lymphoplasmacytic lymphoma: an unusual and intriguing form of SM-AHN.
    Autorzy:
    Bonometti A; Unit of Anatomic Pathology, Department of Molecular Medicine, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy.
    Boveri E; Unit of Anatomic Pathology, IRCCS San Matteo Foundation, Pavia, Italy.
    Varettoni M; Unit of Hematology, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy.
    Ripamonti A; Unit of Anatomic Pathology, Department of Molecular Medicine, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy.
    Fraticelli S; Unit of Anatomic Pathology, Department of Molecular Medicine, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy.
    Lucioni M; Unit of Anatomic Pathology, IRCCS San Matteo Foundation, Pavia, Italy.
    Zibellini S; Unit of Hematology, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy.
    Elena C; Unit of Hematology, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy.
    Pietra D; Unit of Hematology, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy.
    Arcaini L; Unit of Hematology, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy.
    Paulli M; Unit of Anatomic Pathology, Department of Molecular Medicine, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy.
    Pokaż więcej
    Źródło:
    Leukemia & lymphoma [Leuk Lymphoma] 2021 Jul; Vol. 62 (7), pp. 1782-1785. Date of Electronic Publication: 2021 Feb 14.
    Typ publikacji:
    Letter
    MeSH Terms:
    Lymphoma, B-Cell*
    Mast-Cell Sarcoma*
    Mastocytosis, Systemic*/diagnosis
    Mastocytosis, Systemic*/genetics
    Myelodysplastic-Myeloproliferative Diseases*
    Waldenstrom Macroglobulinemia*/diagnosis
    Humans
    Opinia redakcyjna
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers.
    Autorzy:
    Lucioni M; Unit of Anatomic Pathology, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
    Berti E; Department of Dermatology, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico and Università degli Studi di Milano-Bicocca, Milan, Italy.
    Arcaini L; Section of Hematology-Oncology, Department of Molecular Medicine, University of Pavia, Pavia, Italy.
    Croci GA; Unit of Anatomic Pathology, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
    Maffi A; Unit of Anatomic Pathology, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
    Klersy C; Scientific Direction, Biometry and Statistics, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
    Goteri G; Pathologic Anatomy and Histopathology, Department of Biomedical Sciences and Public Health, Polytechnic University of Marche Region, United Ancona Hospitals, Torrette, Ancona, Italy.
    Tomasini C; Pathology Unit, Department of Laboratory Medicine, Azienda Ospedaliera Città della Salute e della Scienza di Torino, Turin, Italy.
    Quaglino P; Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
    Riboni R; Unit of Anatomic Pathology, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
    Arra M; Unit of Anatomic Pathology, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
    Dallera E; Unit of Anatomic Pathology, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
    Grandi V; Division of Dermatology, University of Florence Medical School, Florence, Italy.
    Alaibac M; Dermatologic Clinic, University of Padova, Padova, Italy.
    Ramponi A; Division of Pathology, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.
    Rattotti S; Department of Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
    Cabras MG; Division of Hematology, Osp A Businco, Cagliari, Italy.
    Franceschetti S; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.
    Fraternali-Orcioni G; Anatomic Pathology Division, San Martino University Hospital, Genova, Italy.
    Zerbinati N; Department of Surgical and Morphological Sciences, Faculty of Medicine and Surgery, University of Insubria, Varese, Italy.
    Onida F; Hematology and Bone Marrow Transplantation Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and University of Milan, Milano, Italy.
    Ascani S; Institute of Pathology, Ospedale S. Maria di Terni and University of Perugia, Perugia, Italy.
    Fierro MT; Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
    Rupoli S; Clinic of Hematology, United Ancona Hospitals, Torrette, Ancona, Italy.
    Gambacorta M; Synlab, Italia, Brescia, Italy.
    Zinzani PL; Institute of Hematology 'Seràgnoli', University of Bologna, Bologna, Italy.
    Pimpinelli N; Division of Dermatology, University of Florence Medical School, Florence, Italy.
    Santucci M; Division of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence School of Human Health Sciences, Firenze, Italy.
    Paulli M; Unit of Anatomic Pathology, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. marco.paulli@unipv.it.
    Pokaż więcej
    Źródło:
    Cancer medicine [Cancer Med] 2016 Oct; Vol. 5 (10), pp. 2740-2755. Date of Electronic Publication: 2016 Sep 26.
    Typ publikacji:
    Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Biomarkers, Tumor/*metabolism
    Lymphoma, B-Cell/*classification
    Lymphoma, B-Cell/*pathology
    Skin Neoplasms/*classification
    Skin Neoplasms/*pathology
    Adult ; Aged ; Aged, 80 and over ; Diagnosis, Differential ; Female ; Humans ; Interferon Regulatory Factors/metabolism ; Lymphoma, B-Cell/metabolism ; Male ; Middle Aged ; Neprilysin/metabolism ; Prognosis ; Proto-Oncogene Proteins c-bcl-6/metabolism ; Proto-Oncogene Proteins c-myc/metabolism ; Retrospective Studies ; Skin Neoplasms/metabolism ; Survival Analysis
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II study.
    Autorzy:
    Iannitto E; a A.O.U. Policlinico Paolo Giaccone , Palermo , Italy.
    Luminari S; b University of Modena and Reggio Emilia , Modena , Italy.
    Tripodo C; c University of Palermo , Palermo , Italy.
    Mancuso S; a A.O.U. Policlinico Paolo Giaccone , Palermo , Italy.
    Cesaretti M; b University of Modena and Reggio Emilia , Modena , Italy.
    Marcheselli L; b University of Modena and Reggio Emilia , Modena , Italy.
    Merli F; d Arcispedale S. Maria Nuova - IRCCS , Reggio Emilia , Italy.
    Stelitano C; e Azienda Ospedaliera Bianchi Melacrino Morelli , Reggio Calabria , Italy.
    Carella AM; f Azienda Ospedaliera Universitaria 'San Martino' , Genova , Italy.
    Fragasso A; g Presidio Ospedaliero Madonna delle Grazie , Matera , Italy.
    Montechiarello E; e Azienda Ospedaliera Bianchi Melacrino Morelli , Reggio Calabria , Italy.
    Ricciuti G; h Department of Hematology , Pescara , Italy.
    Pulsoni A; i University La Sapienza , Roma , Italy.
    Paulli M; j University of Pavia and Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Policlinico , San Matteo, Pavia , Italy.
    Franco V; c University of Palermo , Palermo , Italy.
    Federico M; b University of Modena and Reggio Emilia , Modena , Italy.
    Pokaż więcej
    Źródło:
    Leukemia & lymphoma [Leuk Lymphoma] 2015; Vol. 56 (12), pp. 3281-7. Date of Electronic Publication: 2015 Jul 18.
    Typ publikacji:
    Clinical Trial, Phase II; Journal Article; Multicenter Study
    MeSH Terms:
    Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
    Lymphoma, B-Cell/*diagnosis
    Lymphoma, B-Cell/*drug therapy
    Splenic Neoplasms/*diagnosis
    Splenic Neoplasms/*drug therapy
    Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Biomarkers ; Biopsy ; Bone Marrow/pathology ; Cause of Death ; Combined Modality Therapy ; Cyclophosphamide/administration & dosage ; Doxorubicin/administration & dosage ; Doxorubicin/analogs & derivatives ; Female ; Humans ; Immunophenotyping ; Italy ; Kaplan-Meier Estimate ; Lymphoma, B-Cell/mortality ; Male ; Middle Aged ; Polyethylene Glycols/administration & dosage ; Prednisone/administration & dosage ; Prognosis ; Rituximab/administration & dosage ; Splenic Neoplasms/mortality ; Treatment Outcome ; Vincristine/administration & dosage
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.
    Autorzy:
    Todeschini G; Department of Hematology, Verona University, Italy. />Secchi S
    Morra E
    Vitolo U
    Orlandi E
    Pasini F
    Gallo E
    Ambrosetti A
    Tecchio C
    Tarella C
    Gabbas A
    Gallamini A
    Gargantini L
    Pizzuti M
    Fioritoni G
    Gottin L
    Rossi G
    Lazzarino M
    Menestrina F
    Paulli M
    Palestro M
    Cabras MG
    Di Vito F
    Pizzolo G
    Pokaż więcej
    Źródło:
    British journal of cancer [Br J Cancer] 2004 Jan 26; Vol. 90 (2), pp. 372-6.
    Typ publikacji:
    Clinical Trial; Comparative Study; Journal Article; Multicenter Study
    MeSH Terms:
    Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
    Lymphoma, B-Cell/*drug therapy
    Lymphoma, Large B-Cell, Diffuse/*drug therapy
    Lymphoma, Non-Hodgkin/*drug therapy
    Mediastinal Neoplasms/*drug therapy
    Adolescent ; Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Bleomycin/administration & dosage ; Cyclophosphamide/administration & dosage ; Disease-Free Survival ; Doxorubicin/administration & dosage ; Etoposide/administration & dosage ; Female ; Humans ; Leucovorin/administration & dosage ; Lymphoma, B-Cell/pathology ; Lymphoma, Large B-Cell, Diffuse/pathology ; Lymphoma, Non-Hodgkin/pathology ; Male ; Mediastinal Neoplasms/pathology ; Methotrexate/administration & dosage ; Middle Aged ; Prednisone/administration & dosage ; Prognosis ; Retrospective Studies ; Risk Factors ; Treatment Outcome ; Vincristine/administration & dosage
    SCR Protocol:
    CHOP protocol; MACOP-B protocol; VACOP-B protocol
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-4 z 4

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies